NCT04887259 2025-01-27Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AMLLava TherapeuticsPhase 1 Terminated16 enrolled
NCT04023071 2023-10-26FT516 in Subjects With Advanced Hematologic MalignanciesFate TherapeuticsPhase 1 Terminated72 enrolled